General Information of Drug (ID: DMY3K8I)

Drug Name
MB-66
Indication
Disease Entry ICD 11 Status REF
Herpes simplex virus infection 1F00 Phase 1 [1]
Human immunodeficiency virus infection 1C62 Phase 1 [2]
Drug Type
Antibody
Cross-matching ID
TTD ID
D3CG6E
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT02579083) Vaginal Antibody Safety Trial: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) (VAST). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)